Literature DB >> 10526657

Genetic comparisons of patients with cystic fibrosis with or without meconium ileus. Clinical Centers of the French CF Registry.

J Feingold1, M Guilloud-Bataille.   

Abstract

Cystic fibrosis (CF) is an autosomal disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR). Neonatal meconium ileus (MI) occurs in 10-20 percent of newborns with CF. The purpose of this study was to determine the allelic frequencies of the CF mutation in French patients with and without MI and the incidence of MI in 7 homozygotes or compound heterozygotes for mutation of the CFTR gene. Our study confirms the positive association between delta F508, the most frequent CF mutation, G542X mutation and MI and a negative association with G551D.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10526657

Source DB:  PubMed          Journal:  Ann Genet        ISSN: 0003-3995


  9 in total

Review 1.  Cystic fibrosis: an inherited disease affecting mucin-producing organs.

Authors:  Camille Ehre; Caroline Ridley; David J Thornton
Journal:  Int J Biochem Cell Biol       Date:  2014-03-28       Impact factor: 5.085

Review 2.  Stem cell-derived organoids to model gastrointestinal facets of cystic fibrosis.

Authors:  Meike Hohwieler; Lukas Perkhofer; Stefan Liebau; Thomas Seufferlein; Martin Müller; Anett Illing; Alexander Kleger
Journal:  United European Gastroenterol J       Date:  2016-09-21       Impact factor: 4.623

3.  Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis.

Authors:  Scott M Blackman; Rebecca Deering-Brose; Rita McWilliams; Kathleen Naughton; Barbara Coleman; Teresa Lai; Marilyn Algire; Suzanne Beck; Julie Hoover-Fong; Ada Hamosh; M Daniele Fallin; Kristen West; Dan E Arking; Aravinda Chakravarti; David J Cutler; Garry R Cutting
Journal:  Gastroenterology       Date:  2006-07-24       Impact factor: 22.682

4.  Meconium ileus caused by mutations in GUCY2C, encoding the CFTR-activating guanylate cyclase 2C.

Authors:  Hila Romi; Idan Cohen; Daniella Landau; Suliman Alkrinawi; Baruch Yerushalmi; Reli Hershkovitz; Nitza Newman-Heiman; Garry R Cutting; Rivka Ofir; Sara Sivan; Ohad S Birk
Journal:  Am J Hum Genet       Date:  2012-04-19       Impact factor: 11.025

5.  Assessing the Disease-Liability of Mutations in CFTR.

Authors:  Claude Ferec; Garry R Cutting
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

Review 6.  The cystic fibrosis intestine.

Authors:  Robert C De Lisle; Drucy Borowitz
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

7.  Detecting Common CFTR Mutations by Reverse Dot Blot Hybridization Method in Cystic Fibrosis First Report from Northern Iran.

Authors:  Mohammad-Reza Esmaeili Dooki; Haleh Akhavan-Niaki; Ali Ghabeli Juibary
Journal:  Iran J Pediatr       Date:  2011-03       Impact factor: 0.364

8.  Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis.

Authors:  Lindsay B Henderson; Vishal K Doshi; Scott M Blackman; Kathleen M Naughton; Rhonda G Pace; Jackob Moskovitz; Michael R Knowles; Peter R Durie; Mitchell L Drumm; Garry R Cutting
Journal:  PLoS Genet       Date:  2012-03-15       Impact factor: 5.917

9.  Prevalence of meconium ileus marks the severity of mutations of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene.

Authors:  Annie Dupuis; Katherine Keenan; Chee Y Ooi; Ruslan Dorfman; Marci K Sontag; Lutz Naehrlich; Carlo Castellani; Lisa J Strug; Johanna M Rommens; Tanja Gonska
Journal:  Genet Med       Date:  2015-06-18       Impact factor: 8.822

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.